Role of Oxidative Stress and Inflammation in Gestational Diabetes Mellitus.
Renata SaucedoClara Ortega-CamarilloAldo Ferreira-HermosilloMary Flor Díaz-VelázquezClaudia Meixueiro-CalderónJorge ValenciaPublished in: Antioxidants (Basel, Switzerland) (2023)
Gestational diabetes mellitus (GDM) is one of the most common pregnancy complications. It is related to several gestational and fetal adverse outcomes. Moreover, women with GDM and their infants have a high risk of developing type 2 diabetes in the future. The pathogenesis of GDM is not completely understood; nevertheless, two factors that contribute to its development are oxidative stress and inflammation. Oxidative stress and inflammation are related; reactive oxygen species (ROS) production can activate inflammatory cells and enhance the production of inflammatory mediators. Inflammation, in turn, leads to an increased ROS release, causing a vicious circle to ensue. Inflammatory responses can be achieved via the activation of the NF-κB signaling pathway. Herein, we review the English literature regarding oxidative stress and inflammation evaluated simultaneously in the same population, attempting to identify mechanisms through which these factors contribute to the development of GDM. Furthermore, the modulation of oxidative stress and inflammation by different therapies used in women with GDM and in cell models of GDM is included in the review. Probiotics and nutrient supplementations have been shown to reduce biomarkers of inflammation and oxidative stress in vitro and in women with GDM.
Keyphrases
- oxidative stress
- induced apoptosis
- dna damage
- diabetic rats
- ischemia reperfusion injury
- signaling pathway
- type diabetes
- reactive oxygen species
- pregnant women
- systematic review
- cell death
- heat shock
- stem cells
- cardiovascular disease
- body mass index
- immune response
- cell therapy
- insulin resistance
- metabolic syndrome
- preterm birth
- cell cycle arrest
- bone marrow
- nuclear factor